create a 25 slide about therapeutic evolution in immune thromvocytopenia
create a 25 slide about therapeutic evolution in immune thromvocytopenia
Created using ChatSlide
This presentation outlines the evolution of therapeutic strategies in immune thrombocytopenia (ITP), emphasizing a shift from steroid monotherapy to personalized treatment approaches. Key topics include the burden of ITP, treatment thresholds based on disease course, and the importance of durable control in decision-making. The ASH 2026 recommendations advocate for the use of rituximab and TPO agents, prioritizing patient preferences and quality of life. The discussion also covers second-line...